Skip to Content

GG 615 GG 615 (Ranitidine 300 mg)

This pill with imprint "GG 615 GG 615" is Brown, Capsule-shape and has been identified as Ranitidine hydrochloride 300 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Ranitidine is used in the treatment of gerd; erosive esophagitis; gastric ulcer maintenance treatment; duodenal ulcer; zollinger-ellison syndrome (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for GG 615 GG 615

Ranitidine hydrochloride

Imprint:
GG 615 GG 615
Strength:
300 mg
Color:
Brown
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
Inactive Ingredients:
ammonia
corn starch
FD&C Blue No. 1
FD&C Red No. 40
FD&C Yellow No. 6
gelatin
magnesium stearate
propylene glycol
silicon dioxide
sodium lauryl sulfate
sodium starch glycolate type A potato
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide